Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

97.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When?

Clinical genitourinary cancer·2026
Same author

Novel Chitosan Bioink Derived from <i>Eurycantha calcarata</i> (Lucas, 1869) for 3D Bioprinting of Cell-Compatible Scaffolds.

ACS omega·2026
Same author

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Spontaneous Regression of Clear Cell Renal Cell Carcinoma Metastases or Immune Restoration?

Current oncology (Toronto, Ont.)·2026
Same author

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study.

Cancer immunology, immunotherapy : CII·2026

相关实验视频

Updated: Jan 16, 2026

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
09:26

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation

Published on: December 29, 2021

4.8K

ASOG:反感性寡核酸生成器

Jonah Kimi1,2, Patricia Korczak1, Brune Vialet1

  • 1Univ. Bordeaux, CNRS, INSERM, ARNA UMR 5320, U1212, F-33000 Bordeaux, France.

Computational and structural biotechnology journal
|October 6, 2025
PubMed
概括

我们开发了AntiSense Oligonucleotide Generator (ASOG),这是一个用于设计反感性寡核酸 (ASO) 的网络应用程序. ASOG通过预测属性,掩盖拼接位置和检测目标外效应来简化ASO设计.

关键词:
这是一种反意义的寡核酸.在这里,你会得到祝福.化温度计算方法 化温度计算方法拼接地点预测预测网络服务器 网络服务器

更多相关视频

Efficient Generation of hiPSC Neural Lineage Specific Knockin Reporters Using the CRISPR/Cas9 and Cas9 Double Nickase System
14:46

Efficient Generation of hiPSC Neural Lineage Specific Knockin Reporters Using the CRISPR/Cas9 and Cas9 Double Nickase System

Published on: May 28, 2015

11.6K
3' End Sequencing Library Preparation with A-seq2
12:01

3' End Sequencing Library Preparation with A-seq2

Published on: October 10, 2017

11.0K

相关实验视频

Last Updated: Jan 16, 2026

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
09:26

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation

Published on: December 29, 2021

4.8K
Efficient Generation of hiPSC Neural Lineage Specific Knockin Reporters Using the CRISPR/Cas9 and Cas9 Double Nickase System
14:46

Efficient Generation of hiPSC Neural Lineage Specific Knockin Reporters Using the CRISPR/Cas9 and Cas9 Double Nickase System

Published on: May 28, 2015

11.6K
3' End Sequencing Library Preparation with A-seq2
12:01

3' End Sequencing Library Preparation with A-seq2

Published on: October 10, 2017

11.0K

科学领域:

  • 分子生物学分子生物学
  • 生物信息学是一种生物信息学.
  • 计算生物学 计算生物学

背景情况:

  • 反感性寡核酸 (ASOs) 对于调节研究和临床中的基因表达至关重要.
  • 手动的ASO设计耗时,限制了ASO设计空间的探索.
  • 现有的自动化ASO设计工具具有局限性,需要新的方法.

研究的目的:

  • 为自动化反意义寡核酸 (ASO) 设计引入一个通用和原创的管道.
  • 为高效的ASO探索提供一个用户友好的Web应用程序,ASOG.
  • 为了促进在ASO选择研究和治疗应用时的知情决策.

主要方法:

  • 开发一个网络应用程序,AntiSense Oligonucleotide Generator (ASOG),集成明确的标准,原始算法和第三方软件.
  • ASOG管道接受一个目标基因序列用于全面的ASO分析.
  • 预测ASO结构性质,拼接部位掩盖,非目标效应和热力学杂交参数,包括RNA修饰.

主要成果:

  • 通过ASOG,可以快速生成和评估反感性寡核酸 (ASO).
  • 管道预测了对ASO有效性和特异性至关重要的关键参数.
  • 它解释了常见的RNA修改,提高了预测的准确性.

结论:

  • ASOG提供了一种多功能和高效的解决方案,用于导航反意义寡核酸设计空间.
  • 网络服务器使研究人员能够快速识别应用程序的最佳ASO.
  • ASOG代表了促进基于ASO的基因调制策略的重大进展.